Condition
Controlled Hypotension for Nasal Surgeries
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07660562Not ApplicableNot Yet Recruiting
Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal Surgery
NCT07460050Not ApplicableNot Yet RecruitingPrimary
Comparison of Two Sedative Agents in Terms of Controlled Hypotension
NCT03059316Early Phase 1CompletedPrimary
Effect of Hypotensive Anesthesia on the Perfusion Index
Showing all 3 trials